Since CD38 modulation markedly enhanced the NAD+ depletion triggered by the Nampt inhibitor exposure, we assumed that the energy pool may have had a huge impact on the anti-MM effects of our strategy. This evidence concerns the gene NAMPT and Miyoshi myopathy.